Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

8,838 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
RAD21 amplification epigenetically suppresses interferon signaling to promote immune evasion in ovarian cancer.
Deng P, Wang Z, Chen J, Liu S, Yao X, Liu S, Liu L, Yu Z, Huang Y, Xiong Z, Xiao R, Gao J, Liang W, Chen J, Liu H, Hong JH, Chan JY, Guan P, Chen J, Wang Y, Yin J, Li J, Zheng M, Zhang C, Zhou P, Kang T, Teh BT, Yu Q, Zuo Z, Jiang Q, Liu J, Xiong Y, Xia X, Tan J. Deng P, et al. Among authors: zhou p. J Clin Invest. 2022 Nov 15;132(22):e159628. doi: 10.1172/JCI159628. J Clin Invest. 2022. PMID: 36201246 Free PMC article.
CAR-T cells targeting CLL-1 as an approach to treat acute myeloid leukemia.
Wang J, Chen S, Xiao W, Li W, Wang L, Yang S, Wang W, Xu L, Liao S, Liu W, Wang Y, Liu N, Zhang J, Xia X, Kang T, Chen G, Cai X, Yang H, Zhang X, Lu Y, Zhou P. Wang J, et al. Among authors: zhou p. J Hematol Oncol. 2018 Jan 10;11(1):7. doi: 10.1186/s13045-017-0553-5. J Hematol Oncol. 2018. PMID: 29316944 Free PMC article.
Increased vessel perfusion predicts the efficacy of immune checkpoint blockade.
Zheng X, Fang Z, Liu X, Deng S, Zhou P, Wang X, Zhang C, Yin R, Hu H, Chen X, Han Y, Zhao Y, Lin SH, Qin S, Wang X, Kim BY, Zhou P, Jiang W, Wu Q, Huang Y. Zheng X, et al. Among authors: zhou p. J Clin Invest. 2018 May 1;128(5):2104-2115. doi: 10.1172/JCI96582. Epub 2018 Apr 16. J Clin Invest. 2018. PMID: 29664018 Free PMC article.
Dysregulated adaptive immune response contributes to severe COVID-19.
Yu K, He J, Wu Y, Xie B, Liu X, Wei B, Zhou H, Lin B, Zuo Z, Wen W, Xu W, Zou B, Wei L, Huang X, Zhou P. Yu K, et al. Among authors: zhou h, zhou p. Cell Res. 2020 Sep;30(9):814-816. doi: 10.1038/s41422-020-0391-9. Epub 2020 Aug 5. Cell Res. 2020. PMID: 32759967 Free PMC article. No abstract available.
DGKA Mediates Resistance to PD-1 Blockade.
Fu L, Li S, Xiao W, Yu K, Li S, Yuan S, Shen J, Dong X, Fang Z, Zhang J, Chen S, Li W, You H, Xia X, Kang T, Tan J, Chen G, Yang AK, Gao Y, Zhou P. Fu L, et al. Among authors: zhou p. Cancer Immunol Res. 2021 Apr;9(4):371-385. doi: 10.1158/2326-6066.CIR-20-0216. Epub 2021 Feb 19. Cancer Immunol Res. 2021. PMID: 33608256
Defined tumor antigen-specific T cells potentiate personalized TCR-T cell therapy and prediction of immunotherapy response.
He J, Xiong X, Yang H, Li D, Liu X, Li S, Liao S, Chen S, Wen X, Yu K, Fu L, Dong X, Zhu K, Xia X, Kang T, Bian C, Li X, Liu H, Ding P, Zhang X, Liu Z, Li W, Zuo Z, Zhou P. He J, et al. Among authors: zhou p. Cell Res. 2022 Jun;32(6):530-542. doi: 10.1038/s41422-022-00627-9. Epub 2022 Feb 14. Cell Res. 2022. PMID: 35165422 Free PMC article.
8,838 results